C5 and Alzheimer disease: In the context of the Arctic model of AD, overexpression of C5a anaphylatoxin, while overall detrimental, delayed the upregulation of some AD-, complement-, and astrocyte-associated genes that are normally elevated in AD, suggesting a concomitant anti-inflammatory process [67].